HeartCore Enterprises, Inc. announced it regained compliance with Nasdaq's $1.00 minimum bid price rule on April 20, 2026, ensuring its common stock will continue to be listed and traded on the Nasdaq Capital Market.
Key takeaways
The Company received written notice on April 20, 2026, confirming compliance with Nasdaq Listing Rule 5550(a)(2).
The matter regarding the minimum bid price requirement has been officially closed by the Nasdaq Staff.
HeartCore's common stock will continue to be listed and traded on the Nasdaq Capital Market without interruption.
The Company utilized a second 180-day cure period, expiring May 1, 2026, to regain compliance.